Control: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Patients with Nonalcoholic Steatohepatitis

被引：0
|
作者：
Pockros, Paul J. [1 ]
Fuchs, Michael [2 ]
Freilich, Bradley L. [3 ]
Schiff, Eugene R. [4 ]
Kohli, Anita [5 ]
Lawitz, Eric J. [6 ]
Hellstern, Paul A. [7 ]
Cohen, David E. [8 ]
Owens-Grillo, Janet [9 ]
Van Biene, Courtney [9 ]
Shringarpure, Reshma [9 ]
MacConell, Leigh [9 ]
Shapiro, David A. [9 ]
机构：
[1] Scripps Clin, Div Gastroenterol Hepatol, La Jolla, CA 92037 USA
[2] McGuire Vet Affairs Med Ctr, Richmond, VA USA
[3] Kansas City Gastroenterol & Hepatol, Kansas City, MO USA
[4] Univ Miami, Coral Gables, FL 33124 USA
[5] NIH, Bldg 10, Bethesda, MD 20892 USA
[6] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA
[7] Nat Coast Clin Res, Inverness, FL USA
[8] Weill Cornell Med Coll, Joan & Sanford I Weill Cornell Dept Med, New York, NY USA
[9] Intercept Pharmaceut Inc, New York, NY USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1672
引用
下载
收藏
页码：951A / 952A
页数：2
相关论文
共 50 条
  • [31] Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
    Harrison, Stephen A.
    Ruane, Peter J.
    Freilich, Bradley L.
    Neff, Guy
    Patil, Rashmee
    Behling, Cynthia A.
    Hu, Chen
    Fong, Erica
    de Temple, Brittany
    Tillman, Erik J.
    Rolph, Timothy P.
    Cheng, Andrew
    Yale, Kitty
    NATURE MEDICINE, 2021, 27 (07) : 1262 - +
  • [32] Probucol in the treatment of non-alcoholic steatohepatitis: A placebo-controlled double-blind study
    Malekzadeh, R
    Merat, S
    Sotoudeh, M
    Sohrabi, MR
    Naseri-Moghadam, S
    Mikaeli, J
    Farahvash, MJ
    Sotoudahmanesh, R
    Ansari, R
    Khatibian, M
    GASTROENTEROLOGY, 2002, 122 (04) : A24 - A24
  • [33] A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
    Zelber-Sagi, Shira
    Kessler, Ada
    Brazowsky, Eli
    Webb, Muriel
    Lurie, Yoav
    Santo, Moshe
    Leshno, Moshe
    Blendis, Laurence
    Halpern, Zamir
    Oren, Ran
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (05) : 639 - 644
  • [34] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
  • [35] Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: A placebo-controlled, double-blind, randomized trial
    House, AA
    Eliasziw, M
    Urquhart, BL
    Freeman, DJ
    Spence, JD
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (04) : 689 - 694
  • [36] Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized, placebo-controlled trial
    Lindor, KD
    GASTROENTEROLOGY, 2003, 124 (04) : A708 - A709
  • [37] Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study
    Earley, Willie
    Burgess, Maria Victoria
    Rekeda, Ludmyla
    Dickinson, Regan
    Szatmari, Balazs
    Nemeth, Gyorgy
    McIntyre, Roger S.
    Sachs, Gary S.
    Yatham, Lakshmi N.
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (06): : 439 - 448
  • [38] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [39] A randomized, double-blind, placebo-controlled study of acid suppression for the treatment of suspected laryngopharyngeal reflux
    Vaezi, M
    Richter, J
    Stasney, CR
    Spiegel, J
    Hwang, C
    Leathers, T
    Sostek, M
    GASTROENTEROLOGY, 2004, 126 (04) : A22 - A22
  • [40] Oral Administration of β-Glucosylceramide for the Treatment of Insulin Resistance and Nonalcoholic Steatohepatitis: Results of a Double-Blind, Placebo-Controlled Trial
    Lalazar, Gadi
    Zigmond, Ehud
    Weksler-Zangen, Sarah
    Ben Ya'acov, Ami
    Levy, Miriam Sklair
    Hemed, Nilla
    Raz, Itamar
    Ilan, Yaron
    JOURNAL OF MEDICINAL FOOD, 2017, 20 (05) : 458 - 464
12345